Mitochondrial translation is the primary determinant of secondary mitochondrial complex I deficiencies
Kristýna Čunátová,
Marek Vrbacký,
Guillermo Puertas-Frias,
Lukáš Alán,
Marie Vanišová,
María José Saucedo-Rodríguez,
Josef Houštěk,
Erika Fernández-Vizarra,
Jiří Neužil,
Alena Pecinová,
Petr Pecina,
Tomáš Mráček
Affiliations
Kristýna Čunátová
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic; Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy; Veneto Institute of Molecular Medicine, 35129 Padova, Italy
Marek Vrbacký
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
Guillermo Puertas-Frias
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic; Department of Genetics and Microbiology, Faculty of Science, Charles University, 12800 Prague, Czech Republic
Lukáš Alán
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
Marie Vanišová
Laboratory for Study of Mitochondrial Disorders, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic
María José Saucedo-Rodríguez
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic; Department of Cell Biology, Faculty of Science, Charles University, 12800 Prague, Czech Republic
Josef Houštěk
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
Erika Fernández-Vizarra
Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy; Veneto Institute of Molecular Medicine, 35129 Padova, Italy
Jiří Neužil
School of Pharmacy and Medical Science, Griffith University, Southport, Qld 4222, Australia; Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, 25250 Prague, Czech Republic; Department of Pediatrics and Inherited Diseases, First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic; Department of Physiology, Faculty of Science, Charles University, 12800 Prague, Czech Republic
Alena Pecinová
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic; Corresponding author
Petr Pecina
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic; Corresponding author
Tomáš Mráček
Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic; Corresponding author
Summary: Individual complexes of the mitochondrial oxidative phosphorylation system (OXPHOS) are not linked solely by their function; they also share dependencies at the maintenance/assembly level, where one complex depends on the presence of a different individual complex. Despite the relevance of this “interdependence” behavior for mitochondrial diseases, its true nature remains elusive. To understand the mechanism that can explain this phenomenon, we examined the consequences of the aberration of different OXPHOS complexes in human cells. We demonstrate here that the complete disruption of each of the OXPHOS complexes resulted in a decrease in the complex I (cI) level and that the major reason for this is linked to the downregulation of mitochondrial ribosomal proteins. We conclude that the secondary cI defect is due to mitochondrial protein synthesis attenuation, while the responsible signaling pathways could differ based on the origin of the OXPHOS defect.